Co-relation of SARS-CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy

doi:10.5306/wjco.v13.i5.339

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3767)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

159

WORD

HTML

1593

Figures (1-1)

254

Tables (1-3)

575

Sum=2640

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

345

Download

782

Sum=1127

May 24, 2022 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. May 24, 2022; 13(5): 339-351
Published online May 24, 2022. doi: 10.5306/wjco.v13.i5.339

Full Size Figure Download Figure

Figure 1 Forest plot for different parameters (demographic, clinical and laboratory) and 30-d mortality outcomes. GIT: Gastrointestinal tract; HPB: Hepatopancreatobiliary; GUT: Genitourinary tract; HPBT: Hepato-pancreato-biliary tract; EBRT: External beam radiotherapy.

Citation: Narayan S, Talwar V, Goel V, Chaudhary K, Sharma A, Redhu P, Soni S, Jain A. Co-relation of SARS-CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy. World J Clin Oncol 2022; 13(5): 339-351
URL: https://www.wjgnet.com/2218-4333/full/v13/i5/339.htm
DOI: https://dx.doi.org/10.5306/wjco.v13.i5.339